Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 806

1.

Investigation of anti-inflammatory and anti-cancer activity of Justicia adathoda metabolites.

Sudevan S, Parasivam R, Sundar S, Velauthan H, Ramasamy V.

Pak J Pharm Sci. 2019 Jul;32(4):1555-1561.

PMID:
31608874
2.

Rv0807, a putative phospholipase A2 of Mycobacterium tuberculosis; Elucidation through sequence analysis, homology modeling, molecular docking and molecular dynamics studies of potential substrates and inhibitors.

Sundar S, Thangamani L, Manivel G, Kumar P, Shanmughavel P.

J Biomol Struct Dyn. 2019 Oct 6:1-12. doi: 10.1080/07391102.2019.1677499. [Epub ahead of print]

PMID:
31588859
3.

Outcome of HIV Related Kidney Diseases Treated with Combined Antiretroviral Therapy (cART).

Prakash J, Iqbal M, Patel PS, Prakash S, Sundar S, Singh U.

J Assoc Physicians India. 2019 Sep;67(9):18-22.

PMID:
31561682
4.

A Rare Nonvenereal Presentation of Oral Condyloma Acuminatum.

Sudhakar S, Senthil B, Sundar S.

Indian J Dermatol. 2019 Sep-Oct;64(5):419-420. doi: 10.4103/ijd.IJD_543_18. No abstract available.

5.

A molecular signature for CD8+ T cells from visceral leishmaniasis patients.

Singh B, Bhushan Chauhan S, Kumar R, Singh SS, Ng S, Amante F, de Labastida Rivera F, Singh OP, Rai M, Nylen S, Sundar S, Engwerda C.

Parasite Immunol. 2019 Nov;41(11):e12669. doi: 10.1111/pim.12669. Epub 2019 Sep 30.

PMID:
31494954
6.

Magneto-Biosensor for the Detection of Uric Acid Using Citric Acid-Capped Iron Oxide Nanoparticles.

Sundar S, Kwon SJ, Venkatachalam G.

J Nanosci Nanotechnol. 2020 Apr 1;20(4):2144-2153. doi: 10.1166/jnn.2020.17313.

PMID:
31492223
7.

Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.

Lappan R, Classon C, Kumar S, Singh OP, de Almeida RV, Chakravarty J, Kumari P, Kansal S, Sundar S, Blackwell JM.

PLoS Negl Trop Dis. 2019 Sep 6;13(9):e0007444. doi: 10.1371/journal.pntd.0007444. eCollection 2019 Sep.

8.

Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.

Sundar S, Singh A, Agrawal N, Chakravarty J.

Am J Trop Med Hyg. 2019 Oct;101(4):795-798. doi: 10.4269/ajtmh.19-0179.

PMID:
31436156
9.

Late cancer diagnoses: biology triumphs clinical acumen.

Sundar S.

BMJ. 2019 Aug 18;366:l5155. doi: 10.1136/bmj.l5155. No abstract available.

PMID:
31427283
10.

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.

Fakiola M, Singh OP, Syn G, Singh T, Singh B, Chakravarty J, Sundar S, Blackwell JM.

PLoS Negl Trop Dis. 2019 Aug 16;13(8):e0007673. doi: 10.1371/journal.pntd.0007673. eCollection 2019 Aug.

11.

Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.

Phillips A, Kehoe S, Singh K, Elattar A, Nevin J, Balega J, Pounds R, Elmodir A, Pascoe J, Fernando I, Sundar S.

Arch Gynecol Obstet. 2019 Aug 14. doi: 10.1007/s00404-019-05269-8. [Epub ahead of print]

PMID:
31414175
12.

Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia.

Amin AN, Ortendahl JD, Harmon AL, Kamat SA, Stellhorn RA, Chase SL, Sundar SV.

Am J Health Syst Pharm. 2019 Feb 21;76(6):374-380. doi: 10.1093/ajhp/zxy064.

PMID:
31361839
13.

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.

Gentry-Maharaj A, Burnell M, Dilley J, Ryan A, Karpinskyj C, Gunu R, Mallett S, Deeks J, Campbell S, Jacobs I, Sundar S, Menon U.

Am J Obstet Gynecol. 2019 Jul 24. pii: S0002-9378(19)30936-6. doi: 10.1016/j.ajog.2019.07.031. [Epub ahead of print]

14.

Cost and quality of life outcome analysis of postoperative infections after posterior lumbar decompression and fusion.

Pennington Z, Sundar SJ, Lubelski D, Alvin MD, Benzel EC, Mroz TE.

J Clin Neurosci. 2019 Oct;68:105-110. doi: 10.1016/j.jocn.2019.07.025. Epub 2019 Jul 23.

PMID:
31350079
15.

Plasma-grain interaction mediated by streaming non-Maxwellian ions.

Sundar S, Moldabekov ZA.

Phys Rev E. 2019 Jun;99(6-1):063202. doi: 10.1103/PhysRevE.99.063202.

PMID:
31330743
16.

Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.

Singh OP, Gedda MR, Mudavath SL, Srivastava ON, Sundar S.

Nanomedicine (Lond). 2019 Jul;14(14):1911-1927. doi: 10.2217/nnm-2018-0448. Epub 2019 Jul 17.

PMID:
31313971
17.

Banning free speech is counterproductive.

Sundar S.

BMJ. 2019 Jul 16;366:l4626. doi: 10.1136/bmj.l4626. No abstract available.

PMID:
31311784
18.

Quality of life outcomes following surgery for advanced ovarian cancer: a systematic review and meta-analysis.

Kumar S, Long J, Kehoe S, Sundar S, Cummins C.

Int J Gynecol Cancer. 2019 Oct;29(8):1285-1291. doi: 10.1136/ijgc-2018-000125. Epub 2019 Jul 3.

PMID:
31273066
19.

Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Sundar S, Agrawal N, Singh B.

Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):595-612. doi: 10.1080/17425255.2019.1629417. Epub 2019 Jun 17. Review.

PMID:
31174439
20.

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.

Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O'Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell JM, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ.

Eur Urol Oncol. 2018 Dec;1(6):449-458. doi: 10.1016/j.euo.2018.06.004. Epub 2018 Sep 14.

21.

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3).

NIHR Global Health Research Uniton Global Surgery.

BMJ Open. 2019 May 24;9(5):e026646. doi: 10.1136/bmjopen-2018-026646.

22.

Black women with postmenopausal bleeding have lower prevalence of endometrial cancer than other ethnic groups.

Ghoubara A, Sundar S, Ewies AAA.

Climacteric. 2019 Dec;22(6):632-636. doi: 10.1080/13697137.2019.1606794. Epub 2019 May 20.

PMID:
31104512
23.

Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.

Veronica J, Chandrasekaran S, Dayakar A, Devender M, Prajapati VK, Sundar S, Maurya R.

FEBS J. 2019 Sep;286(17):3488-3503. doi: 10.1111/febs.14923. Epub 2019 Jun 1.

PMID:
31087522
24.

Current and emerging medications for the treatment of leishmaniasis.

Chakravarty J, Sundar S.

Expert Opin Pharmacother. 2019 Jul;20(10):1251-1265. doi: 10.1080/14656566.2019.1609940. Epub 2019 May 7. Review.

PMID:
31063412
25.

Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis.

Bremer Hinckel BC, Marlais T, Airs S, Bhattacharyya T, Imamura H, Dujardin JC, El-Safi S, Singh OP, Sundar S, Falconar AK, Andersson B, Litvinov S, Miles MA, Mertens P.

PLoS Negl Trop Dis. 2019 May 6;13(5):e0007353. doi: 10.1371/journal.pntd.0007353. eCollection 2019 May.

26.

Characterization of Alzheimer conditions in MR images using volumetric and sagittal brainstem texture features.

Rohini P, Sundar S, Ramakrishnan S.

Comput Methods Programs Biomed. 2019 May;173:147-155. doi: 10.1016/j.cmpb.2019.03.003. Epub 2019 Mar 7.

PMID:
31046989
27.
28.

High sensitivity troponin assays: too much of a good thing.

Sundar S.

BMJ. 2019 Apr 16;365:l1640. doi: 10.1136/bmj.l1640. No abstract available.

PMID:
30992262
29.

Palliative care: relocation rather than rebranding is needed.

Sundar S.

BMJ. 2019 Apr 10;365:l1641. doi: 10.1136/bmj.l1641. No abstract available.

PMID:
30971413
30.

Human Papillomavirus Genome based Detection and Typing: A Holistic Molecular Approach.

Gautam A, Gedda MR, Rai M, Sundar S, Chakravarty J.

Curr Mol Med. 2019;19(4):237-246. doi: 10.2174/1566524019666190405120441.

PMID:
30950352
31.

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.

Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S.

PLoS Negl Trop Dis. 2019 Mar 27;13(3):e0007216. doi: 10.1371/journal.pntd.0007216. eCollection 2019 Mar.

32.

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.

Joshi S, Yadav NK, Rawat K, Kumar V, Ali R, Sahasrabuddhe AA, Siddiqi MI, Haq W, Sundar S, Dube A.

Front Immunol. 2019 Feb 28;10:288. doi: 10.3389/fimmu.2019.00288. eCollection 2019.

33.

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Goranova T, Ennis D, Piskorz AM, Macintyre G, Lewsley LA, Stobo J, Wilson C, Kay D, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Freeman S, Moore L, Jimenez-Linan M, Paul J, Brenton JD, McNeish IA; BriTROC investigators.

Br J Cancer. 2019 Apr;120(8):868. doi: 10.1038/s41416-019-0433-6.

34.

Renaming low risk cancers: honest engagement with patients is more important.

Sundar S.

BMJ. 2019 Feb 26;364:l840. doi: 10.1136/bmj.l840. No abstract available.

PMID:
30808719
35.

Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.

Chauhan SB, Faleiro R, Kumar R, Ng S, Singh B, Singh OP, Singh SS, Amante F, Rivera FL, Rai M, Chakravarty J, Sacks D, Nylen S, Sundar S, Engwerda C.

J Infect Dis. 2019 Jun 5;220(1):163-173. doi: 10.1093/infdis/jiz074.

PMID:
30796820
36.

Abnormal B-Cell Subset and Blimp-1-Mediated Humoral Responses Associated With Visceral Leishmaniasis Pathogenesis.

Singh B, Singh OP, Singh N, Singh SS, Sundar S.

Am J Trop Med Hyg. 2019 Apr;100(4):816-821. doi: 10.4269/ajtmh.18-0350.

PMID:
30793688
37.

Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.

Abeijon C, Alves F, Monnerat S, Wasunna M, Mbui J, Viana AG, Bueno LL, Siqueira WF, Carvalho SG, Agrawal N, Fujiwara R, Sundar S, Campos-Neto A.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e02076-18. doi: 10.1128/JCM.02076-18. Print 2019 May.

PMID:
30787142
38.

A new scoring system for prediction of meniscal repair in traumatic meniscal tears.

Kumaraswamy V, Ramaswamy AG, Sundar S, Rajan DV, Selvaraj K, Sahanand S, Deebak S.

Knee Surg Sports Traumatol Arthrosc. 2019 Nov;27(11):3454-3460. doi: 10.1007/s00167-019-05377-7. Epub 2019 Feb 8.

PMID:
30734836
39.

The effects of added mass on the biomechanics and performance of countermovement jumps.

Harrison AJ, Byrne P, Sundar S.

J Sports Sci. 2019 Jul;37(14):1591-1599. doi: 10.1080/02640414.2019.1577120. Epub 2019 Feb 6.

PMID:
30724701
40.

Global burden of postoperative death.

Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A; National Institute for Health Research Global Health Research Unit on Global Surgery.

Lancet. 2019 Feb 2;393(10170):401. doi: 10.1016/S0140-6736(18)33139-8. No abstract available.

PMID:
30722955
41.

Eliminating visceral leishmaniasis in South Asia: the road ahead.

Rijal S, Sundar S, Mondal D, Das P, Alvar J, Boelaert M.

BMJ. 2019 Jan 22;364:k5224. doi: 10.1136/bmj.k5224. No abstract available.

42.

Direct synthesis of 2,4,5-trisubstituted imidazoles from primary alcohols by diruthenium(ii) catalysts under aerobic conditions.

Sundar S, Rengan R.

Org Biomol Chem. 2019 Feb 6;17(6):1402-1409. doi: 10.1039/c8ob02785d.

PMID:
30663756
43.

Chronic hyponatremia and association with osteoporosis among a large racially/ethnically diverse population.

Adams AL, Li BH, Bhandari S, Kamat S, Sundar S, Krasa H, Rhee CM, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ.

Osteoporos Int. 2019 Apr;30(4):853-861. doi: 10.1007/s00198-018-04832-4. Epub 2019 Jan 11.

PMID:
30635697
44.

Prioritizing research for patients requiring surgery in low- and middle-income countries.

National Institute for Health Research Global Health Research Unit on Global Surgery.

Br J Surg. 2019 Jan;106(2):e113-e120. doi: 10.1002/bjs.11037.

PMID:
30620063
45.

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.

Marlais T, Bhattacharyya T, Singh OP, Mertens P, Gilleman Q, Thunissen C, Hinckel BCB, Pearson C, Gardner BL, Airs S, de la Roche M, Hayes K, Hafezi H, Falconar AK, Eisa O, Saad A, Khanal B, Bhattarai NR, Rijal S, Boelaert M, El-Safi S, Sundar S, Miles MA.

Front Cell Infect Microbiol. 2018 Dec 13;8:427. doi: 10.3389/fcimb.2018.00427. eCollection 2018.

46.

What Happens When You Click and Drag: Unpacking the Relationship between On-Screen Interaction and User Engagement with an Anti-Smoking Website.

Oh J, Sundar SS.

Health Commun. 2019 Jan 8:1-12. doi: 10.1080/10410236.2018.1560578. [Epub ahead of print]

PMID:
30618306
47.

Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India.

Gautam A, Chakravarty J, Singh VK, Ghosh A, Chauhan SB, Rai M, Sundar S.

BMC Infect Dis. 2018 Dec 27;18(1):692. doi: 10.1186/s12879-018-3618-3.

48.

Leishmania donovani evades Caspase 1 dependent host defense mechanism during infection.

Saha G, Khamar BM, Singh OP, Sundar S, Dubey VK.

Int J Biol Macromol. 2019 Apr 1;126:392-401. doi: 10.1016/j.ijbiomac.2018.12.185. Epub 2018 Dec 22.

PMID:
30584943
49.

Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.

Mollett G, Bremer Hinckel BC, Bhattacharyya T, Marlais T, Singh OP, Mertens P, Falconar AK, El-Safi S, Sundar S, Miles MA.

Clin Infect Dis. 2019 Sep 13;69(7):1130-1135. doi: 10.1093/cid/ciy1062.

50.

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India.

Bulstra CA, Le Rutte EA, Malaviya P, Hasker EC, Coffeng LE, Picado A, Singh OP, Boelaert MC, de Vlas SJ, Sundar S.

PLoS Negl Trop Dis. 2018 Dec 6;12(12):e0006888. doi: 10.1371/journal.pntd.0006888. eCollection 2018 Dec.

Supplemental Content

Loading ...
Support Center